Can KSM-66 Ashwagandha Help with Chronic Stress and Adrenal Fatigue? Here's What the Research Actually Shows
By the time most people start searching for answers about "adrenal fatigue," they've already cut caffeine, forced eight hours of sleep, and tried to push through the afternoon crash with sheer willpower. None of it touches the underlying problem: a stress-response system that never gets the signal to stand down. KSM-66 Ashwagandha, the most clinically researched full-spectrum ashwagandha extract on the market, has been the subject of more than two dozen human trials examining exactly this — what happens when cortisol output stays chronically elevated, and whether a standardized adaptogen can bring it back into range.
Chronic, unresolved stress keeps cortisol elevated long after the original stressor is gone — the physiological signature of what's commonly called adrenal fatigue.
According to the American Psychological Association's annual Stress in America survey, a majority of U.S. adults report that stress interferes with their daily functioning, and nearly a quarter describe it as unmanageable most days. "Adrenal fatigue" isn't a formal endocrinology diagnosis, but the cluster of symptoms it describes — persistent tiredness, sugar and salt cravings, brain fog, and a "wired but tired" feeling at night — maps closely onto a well-documented physiological state known as HPA axis dysregulation.
When stress is chronic rather than acute, the hypothalamic-pituitary-adrenal (HPA) axis stops resetting properly. Cortisol, meant to spike and then fall, instead stays elevated or becomes erratic, disrupting blood sugar regulation, sleep architecture, and immune function along the way.
A 60-day, randomized, double-blind, placebo-controlled study published in the Indian Journal of Psychological Medicine gave 64 adults with a history of chronic stress either 300mg of KSM-66 twice daily or a placebo. The ashwagandha group showed a 27.9% reduction in serum cortisol, compared to a 7.9% reduction in the placebo group, along with significant improvements on the Perceived Stress Scale (1).
Not every ashwagandha product produces this result. KSM-66 is a root-only extract standardized to a minimum of 5% withanolides, using a proprietary water-based extraction process that avoids alcohol and harsh solvents — which is why it's the specific form used in the majority of the 24+ published human clinical trials on ashwagandha to date, including the study above.
This article breaks down exactly how KSM-66 affects the stress-response system, what the clinical evidence shows across cortisol, sleep, thyroid, and anxiety markers, how to dose it correctly, and who should — and shouldn't — consider it.
What Is KSM-66 Ashwagandha?
Withania somnifera, known as ashwagandha or Indian ginseng, is a root classified in Ayurvedic medicine as a rasayana — a category of herbs traditionally used to restore vitality, resilience, and balance during periods of prolonged stress or illness. It has been used in Ayurvedic formulations for more than 3,000 years, primarily for fatigue, low resilience, and disrupted sleep.
The root's primary bioactive compounds are a class of steroidal lactones called withanolides. Withanolides are believed to help regulate the HPA axis and modulate cortisol output, which is the mechanism most directly tied to ashwagandha's effects on stress and fatigue.
KSM-66 is a specific, patented full-spectrum root extract manufactured using a proprietary water-based extraction process that preserves the root's natural withanolide ratio without alcohol or chemical solvents. It is standardized to ≥5% withanolides, contains only root material (not leaf, which carries a different and less-studied compound profile), and is the ashwagandha extract used in more human clinical trials than any other branded form — more than 24 published studies as of this writing.
How KSM-66 Ashwagandha Works: Calming an Overactive Stress Response
The HPA axis is the body's central stress-response circuit. When the brain perceives a threat — physical or psychological — the hypothalamus signals the pituitary gland, which signals the adrenal glands to release cortisol.
In a healthy stress response, cortisol rises quickly, helps the body respond, then falls back to baseline once the stressor passes. Under chronic stress, this feedback loop becomes impaired: the hypothalamus and pituitary gland stop receiving the "stand down" signal effectively, and the adrenal glands continue producing cortisol at elevated or erratic levels well after the original stressor is gone.
This is the physiological state colloquially referred to as adrenal fatigue — not that the adrenal glands themselves are "worn out," but that the entire regulatory loop between brain and adrenal gland has lost its ability to self-correct.
Withanolides appear to support this feedback loop at multiple points. Research suggests they may help modulate upstream signaling from the hypothalamus, support GABAergic activity that counteracts the nervous system's stress response, and reduce oxidative stress markers associated with prolonged cortisol exposure (1) (2).
The net effect documented across trials: measurably lower serum cortisol, reduced self-reported stress and anxiety scores, and in several studies, improvements in sleep quality and daytime energy — the three areas most people associate with "adrenal fatigue" recovery.
The HPA axis stress loop: withanolides appear to act at the hypothalamus, pituitary, and adrenal level to help normalize cortisol output.
What the Clinical Research Shows
Chronic Stress and Cortisol Reduction
The most cited KSM-66 trial, published in the Indian Journal of Psychological Medicine (2012), followed 64 adults with a history of chronic stress over 60 days. Participants taking 300mg of KSM-66 twice daily saw serum cortisol drop by 27.9%, compared with 7.9% in the placebo group, alongside significant reductions on the Perceived Stress Scale and General Health Questionnaire (1).
A separate randomized, double-blind, placebo-controlled trial published in Medicine gave 60 adults 240mg of a standardized ashwagandha extract daily for 60 days and found significant reductions in serum cortisol and self-reported stress compared to placebo, with no serious adverse events reported (2).
Sleep Quality and Stress Recovery
A double-blind, randomized, placebo-controlled study in Cureus gave 60 adults with self-reported sleep difficulty either 300mg of KSM-66 twice daily or placebo for 8 weeks. The ashwagandha group showed significant improvement on the Pittsburgh Sleep Quality Index and sleep-onset latency compared to placebo, along with measurable reductions in Perceived Stress Scale scores (3).
Thyroid and Metabolic Stress Markers
Because chronic stress and elevated cortisol interact with thyroid hormone regulation, several trials have examined ashwagandha's effect on thyroid-stimulating hormone (TSH), T3, and T4. A randomized, double-blind, placebo-controlled trial in the Journal of Alternative and Complementary Medicine found that 600mg/day of ashwagandha root extract over 8 weeks significantly improved thyroid hormone levels in subclinically hypothyroid adults compared to placebo (4).
Anxiety and Self-Reported Well-Being
A study in the journal Medicine (Baltimore) using 240mg/day of a KSM-66-equivalent extract over 60 days reported a 44% reduction in Hamilton Anxiety Rating Scale scores, compared to 5.5% in the placebo group (2).
Dosage, Form, and What to Look For on the Label
Across the human clinical trial literature, the effective dose range for KSM-66 Ashwagandha is 300–600mg per day, typically split into two doses of 300mg taken morning and evening, or a single 600mg dose. Most trials ran for 60–90 days, with participants reporting meaningful reductions in perceived stress beginning around week 2–4 and continued improvement through week 8.
What to look for on the label:
- Ingredient specifically listed as KSM-66® or Withania somnifera root extract (KSM-66)
- Standardized to ≥5% withanolides
- Root extract only (not leaf or whole-plant)
- Minimum 600mg per serving
- Third-party tested (NSF, Informed Sport, or equivalent)
Avoid products that simply list "ashwagandha extract" or "ashwagandha powder" without specifying a standardized, branded extract — these products typically contain trace or inconsistent amounts of withanolides and will not replicate the clinical outcomes documented in published trials.
Safety Profile and Side Effects
KSM-66 has been evaluated in dozens of human clinical trials, generally at doses of 300–600mg/day for periods of up to 12 weeks, and has consistently shown a favorable safety profile with no significant difference in adverse events compared to placebo.
Mild side effects reported in a minority of participants include:
- Mild GI upset if taken on an empty stomach
- Mild sedation (particularly with evening dosing — generally considered beneficial for sleep)
- Rare cases of vivid dreams
Take with food or a small snack to minimize GI sensitivity, especially during the first two weeks.
Who Should — and Shouldn't — Take KSM-66
Ideal Candidates
- Adults experiencing chronic, unresolved stress with persistent fatigue, brain fog, or a "wired but tired" feeling
- Individuals with elevated perceived stress affecting sleep quality or daytime energy
- Adults seeking a standardized, clinically studied adaptogen rather than a generic ashwagandha product
Who Should Consult a Physician First
- Pregnant or breastfeeding individuals: Ashwagandha has not been adequately studied in pregnancy and is generally not recommended.
- Thyroid disorders: Ashwagandha can raise thyroid hormone levels; anyone on thyroid medication should consult a physician before use.
- Autoimmune conditions: As an immune-modulating herb, ashwagandha may not be appropriate for those with autoimmune diseases such as Hashimoto's or lupus without medical guidance.
- Those on sedatives or thyroid medication: Ashwagandha may amplify the effects of sedative medications and interact with thyroid hormone replacement therapy.
Daily Nutra KSM-66 Ashwagandha 600mg Capsules
Each serving delivers 600mg of clinically studied KSM-66® ashwagandha root extract, standardized to ≥5% withanolides — the exact form and dose used in published human clinical trials on cortisol reduction, sleep quality, and stress resilience. No fillers, no proprietary blends. Just the root extract that works.
Shop KSM-66 Ashwagandha →References
- Chandrasekhar K, Kapoor J, Anishetty S. (2012). A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian Journal of Psychological Medicine. PubMed
- Lopresti AL, Smith SJ, Malvi H, Kodgule R. (2019). An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract: A randomized, double-blind, placebo-controlled study. Medicine (Baltimore). PubMed
- Langade D, Kanchi S, Salve J, Debnath K, Ambegaokar D. (2021). Efficacy and safety of ashwagandha (Withania somnifera) root extract in insomnia and anxiety: A double-blind, randomized, placebo-controlled study. Cureus. PubMed
- Sharma AK, Basu I, Singh S. (2018). Efficacy and safety of ashwagandha root extract in subclinical hypothyroid patients: A double-blind, randomized placebo-controlled trial. Journal of Alternative and Complementary Medicine. PubMed
